Did you know?

Track Moderna Inc (MRNA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe Atossa Genetics stock price fell by -6.13% on the last day (Wednesday, 22nd May 2024) from $1.63 to $1.53. During the last trading day the stock fluctuated 8.57% from a day low at $1.51 to a day high of $1.64. The price has risen in 5 of the last 10 days but is still down by -8.93% for this period. Volume has increased on the last day by ...SEATTLE, March 18, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ( Atossa or the Company ), today announced that on March 15, 2024, the Company received written notice from... Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors Globe Newswire • 2 months ago.Atossa Therapeutics (ATOS) Maxim Group analyst Jason McCarthy maintained a Buy rating on Atossa Therapeutics yesterday and set a price target of $4.00. The company's shares closed last Wednesday ...52 Week Low Date 11/13/23. Market Cap 196.727M. Shares Out 125.30M. 10 Day Average Volume 1.49M. Dividend -. Dividend Yield -. Beta 1.24. YTD % Change 78.41.ATOS is more shorted than BB, NOK, and AMC. Get ready for a massive short squeeze Reply ... People with pump this up and spread rumors about this being a huge COVID play, stocktwits will go off about how an announcement is incoming, etc. Then people will inevitably be disappointed that there isn't more information provided about the trial ...SEATTLE, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet ...Oct 24, 2022 · Atossa to begin Phase 2 Study of (Z)-endoxifen in 4th Quarter SEATTLE, Oct. 24, 2022 — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology with a current focus on breast cancer, announced today that the U.S. Food and Drug Administration […]The latest messages and market ideas from OEL ATOS (@fairplyplease) on Stocktwits. The largest community for investors and traders. The latest messages and market ideas from OEL ATOS (@fairplyplease) on Stocktwits. ... OEL ATOS. Follow. Strategy: Equities Growth Intermediate. Joined 7/2013. 1 Following 3 Followers.Track ITeos Therapeutics Inc (ITOS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsOct 24, 2022 · Atossa to begin Phase 2 Study of (Z)-endoxifen in 4th Quarter SEATTLE, Oct. 24, 2022 — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology with a current focus on breast cancer, announced today that the U.S. Food and Drug Administration […]Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.People with pump this up and spread rumors about this being a huge COVID play, stocktwits will go off about how an announcement is incoming, etc. Then people will inevitably be disappointed that there isn’t more information provided about the trial during this conference. Or they will anticipate a dump and will sell. Rinse and repeat.Track A.O. Smith Corp. (AOS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMar 3, 2024 · When Atossa Therapeutics last reported its September 2023 balance sheet in November 2023, it had zero debt and cash worth US$94m. In the last year, its cash burn was US$20m. That means it had a ...Track NVIDIA Corp (NVDA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAtossa Therapeutics, Inc. Announces Last Patient, Last Dose in Its Phase 2 Karisma-Endoxifen Clinical Trial. May. 15. CI. Atossa Therapeutics Files $100 Million Mixed-Shelf Offering. May. 13. MT. Atossa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024.Track Ocugen Inc (OCGN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAtossa Therapeutics, Inc. (ATOS) Stock Price, News, Quote & History - Yahoo Finance. NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Add to watchlist. 1.4600 …Track Scynexis Inc (SCYX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsATOS. Atossa Therapeutics Inc. May 24 • 04:00PM ET. 1.46. 0.00 0.00% Healthcare • Biotechnology • USA • NASD. Chart • Compare Perf. • Revenue • Dividends • Options • …Track Arm Holdings Plc. (ARM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Dark Pulse Inc (DPLS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe latest setback for Atos, which came just weeks after the collapse of a deal to raise urgently-needed cash through the sale of another part of the business, sent its shares down 19.16% to a ...Personalize your watchlist to follow the stocWe would like to show you a description he Track Asensus Surgical Inc (ASXC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Track CytoDyn Inc (CYDY) Stock Price, Quote, lat Jun 12, 2023 · SEATTLE, June 12, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative...Atossa Therapeutics released its earnings results on Apr 01, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.065 by $0.005. Is Atossa Therapeutics overvalued? According to Wall Street analysts Atossa Therapeutics’s price is currently Undervalued. Introducing Litepaper, a newsletter by Stocktwits. Your lens

Atossa Therapeutics Inc. ATOS | Complete Atossa Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial …Find the latest Atos SE (ATO.PA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines. SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced its support of new guidelines released by the U.S. Preventive Services Task Force (USPSTF) recommending that women begin breast cancer screening starting at age 40.Track Dark Pulse Inc (DPLS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAnatoly Gavrilov. Introducing Litepaper, a newsletter by Stocktwits. Your lens into the world of crypto. The latest messages and market ideas from Anatoly Gavrilov (@Atos) on Stocktwits. The largest community for investors and traders.

Atos to call an EGM to approve this comprehensive plan. Atos contemplates to accelerate value creation and complete its strategic transformation and full separation of Eviden and Tech Foundations, as announced in June 2022. Following an in-depth review of its options, Atos’ Board of Directors decided to enter into exclusive negotiations with ...Atossa Therapeutics (ATOS) Maxim Group analyst Jason McCarthy maintained a Buy rating on Atossa Therapeutics yesterday and set a price target of $4.00. The company's shares closed last Wednesday ...After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Track Immunic Inc (IMUX) Stock Price, Quote, late. Possible cause: Feb 5, 2024 ... Atos ditches share sale for bank talks, shares plunge ... (Reu.